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Abstract
Background: There is international interest in enhancing recruitment of minority ethnic people into research, particularly in
disease areas with substantial ethnic inequalities. A recent systematic review and meta-analysis found that UK South Asians
are at three times increased risk of hospitalisation for asthma when compared to white Europeans. US asthma trials are far
more likely to report enrolling minority ethnic people into studies than those conducted in Europe. We investigated
approaches to bolster recruitment of South Asians into UK asthma studies through qualitative research with US and UK
researchers, and UK community leaders.
Methods and Findings: Interviews were conducted with 36 researchers (19 UK and 17 US) from diverse disciplinary
backgrounds and ten community leaders from a range of ethnic, religious, and linguistic backgrounds, followed by self-
completion questionnaires. Interviews were digitally recorded, translated where necessary, and transcribed. The Framework
approach was used for analysis. Barriers to ethnic minority participation revolved around five key themes: (i) researchers’
own attitudes, which ranged from empathy to antipathy to (in a minority of cases) misgivings about the scientific
importance of the question under study; (ii) stereotypes and prejudices about the difficulties in engaging with minority
ethnic populations; (iii) the logistical challenges posed by language, cultural differences, and research costs set against the
need to demonstrate value for money; (iv) the unique contexts of the two countries; and (v) poorly developed
understanding amongst some minority ethnic leaders of what research entails and aims to achieve. US researchers were
considerably more positive than their UK counterparts about the importance and logistics of including ethnic minorities,
which appeared to a large extent to reflect the longer-term impact of the National Institutes of Health’s requirement to
include minority ethnic people.
Conclusions: Most researchers and community leaders view the broadening of participation in research as important and
are reasonably optimistic about the feasibility of recruiting South Asians into asthma studies provided that the barriers can
be overcome. Suggested strategies for improving recruitment in the UK included a considerably improved support structure
to provide academics with essential contextual information (e.g., languages of particular importance and contact with local
gatekeepers), and the need to ensure that care is taken to engage with the minority ethnic communities in ways that are
both culturally appropriate and sustainable; ensuring reciprocal benefits was seen as one key way of avoiding gatekeeper
fatigue. Although voluntary measures to encourage researchers may have some impact, greater impact might be achieved if
UK funding bodies followed the lead of the US National Institutes of Health requiring recruitment of ethnic minorities. Such
a move is, however, likely in the short- to medium-term, to prove unpopular with many UK academics because of the added
‘‘hassle’’ factor in engaging with more diverse populations than many have hitherto been accustomed to.
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Introduction
There is now a considerable body of evidence to show that
minority ethnic people in the UK, US, and many other countries
have overall poorer health outcomes for a range of conditions than
the majority population [1]. Although the reasons underpinning
these inequalities are complex and multifaceted, one approach that
could be important in helping redress these inequalities is that of
focusing research attention on these high risk populations.
Developing strategies to involve minority ethnic people in research
is hence increasingly being seen as a challenge for multi-ethnic
societies; this need is most acutely being recognised in disease areas
in which there are known ethnic inequalities in health outcomes [2].
Asthma is one such disease area, as work has shown that UK people
of South Asian (where South Asians are defined as people whose
ancestry is in the countries of the Indian subcontinent, including
India, Pakistan, Bangladesh, and Sri Lanka) and Black:African
Caribbean origin are, compared with white Europeans, at
significantly increased risk of admission for asthma (South Asians,
odds ratio [OR] 2.9, 95% confidence interval [CI] 2.4–3.4 and
Black: African Caribbean, OR 2.1, 95% CI 1.8–2.5) [3].
Evidence from the UK, however, indicates that minority ethnic
people are markedly under-represented in research, raising
important ethical and legal concerns and also potentially limiting
the generalisability of study findings [4–9]. Comparative US-
European data reveal that minority ethnic people are significantly
more likely to be recruited into asthma trials in the US than in
Europe (62.9% versus 2.9%; p,0.0001) [10].
It has been suggested that these differences may be due to
differences in research policy between the US and UK, in
particular the possible impact of the National Institutes of Health’s
(NIH) 1993 Revitalization Act (see Box 1) [11]. Equally there may
be other important factors such as differing migration contexts and
histories, demographic profiles, and broader linguistic and
religious considerations. For example, non-white ethnic minorities
account for over 30% of the US population [12] compared to an
overall proportion of approximately 8% of the UK population
(although there are cities such as London and Birmingham where
the proportion is much higher) [13]. Not engaging such a large
proportion of the population potentially has far greater conse-
quences than a relatively smaller population as is the case in the
UK. Also potentially relevant is that the UK has a National Health
Service (NHS) which is ‘‘free at the point of delivery,’’ in contrast
with the US, which has a private health care system.
We sought to understand possible reasons explaining these
differences in recruitment rates between the UK and US and to
offer insights to help guide the development of strategies to
facilitate the recruitment of minority ethnic people into future UK
studies by undertaking a qualitative case study focusing on the
UK’s South Asian population in the context of asthma research.
This group was selected because South Asians now represent the
UK’s largest minority ethnic grouping and it is the population for
which inequalities in asthma are best described and most
pronounced.
Methodology and Methods
Ethics Statement
Ethics approval was obtained from St Mary’s Hospital research
ethics committee and research governance approvals were
obtained from London, Brent, Harrow, Lothian, Tower Hamlets,
Barts and The London and Charing Cross and Westminster
research and development boards. Signed informed consent was
obtained from all participants.
Methodology
In order to explore these considerations we decided on using a
qualitative interpretivist approach, as we were particularly
interested in identifying and understanding people’s ideas,
experiences, and perceptions on the importance (or otherwise) of
this subject [14,15]. Our investigations consisted of exploring the
views of UK-based asthma researchers from a range of relevant
disciplinary backgrounds, and the experiences of US researchers as
a comparator, because of the potential comparison in highlighting
the impact of the different demographic, political, socioeconomic,
and legal contexts between these two countries. In addition, we
conducted interviews with UK community leaders and focus
groups with South Asian people with asthma to understand their
experiences and views surrounding this issue. This article, which
focuses on the policy relevant data, draws on interviews with
academics and community leaders (the data from the focus groups
with people with asthma will be reported separately and will not be
considered further in this paper).
Study Design
In-depth interviews were conducted with asthma researchers
from the UK and US. We provided a supplementary question-
naire to researchers and the invitation to post anonymised
comments onto a Web site, thereby providing the opportunity to
offer additional comments confidentially. In addition, we inter-
viewed UK-based South Asian community leaders. Table 1
summarises the techniques used to generate data from these
groups of participants.
Box 1. Key Features of NIH Policy in Relation
to Recruitment of Women and Minorities
The 1993 NIH Revitalization Act (enforced from 1994 and
revised in 2001) resulted in the NIH instituting a policy that
‘‘requires all grants, contracts, and intramural projects
conducting clinical research to address the Inclusion of
Women and Minorities.’’ The NIH defines clinical research
as: ‘‘(1) Patient-oriented research. Research conducted with
human subjects (or on material of human origin such as
tissues, specimens and cognitive phenomena) for which an
investigator (or colleague) directly interacts with human
subjects. Excluded from this definition are in vitro studies
that utilize human tissues that cannot be linked to a living
individual. Patient-oriented research includes: (a) mecha-
nisms of human disease, (b) therapeutic interventions, (c)
clinical trials, or (d) development of new technologies. (2)
Epidemiologic and behavioral studies. (3) Outcomes
research and health services research.’’
The NIH policy places a responsibility on principal
investigators to ‘‘assess the theoretical and/or scientific
linkages between gender, race/ethnicity and their topic of
study’’ in order to:
N ‘‘ensure that women and members of minorities and
their subpopulations are included in all human research;
N for Phase III clinical trials, ensure that women and
minorities and their subpopulations must be included
such that valid analyses of differences in intervention
effect can be accomplished;
N not allow cost as an acceptable reason for excluding
these groups; and
N initiate programs and support for outreach efforts to
recruit these groups into clinical studies.’’
Inclusion of Minority Ethnic People
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Sampling and Recruitment Procedures
US and UK researchers. A database of principal investigators
of recent (2001–2006) asthma projects was compiled through
conducting Medline searches, searching the databases of the US
NIH and UK National Research Register, Asthma UK, and the
Cochrane Airways Group, and contacts with experts. Purposeful
sampling was employed to identify researchers from a wide range of
disciplinary backgrounds (i.e., genetics, basic sciences, epidemiology,
statistics, primary and secondary care, and quantitative and
qualitative research), and likely expertise in and experiences of
recruiting minority ethnic people into research. We constructed a
sampling matrix and began by recruiting broadly across these
potentially relevant data fields and then sampling to fill in any
important gaps; subsequent sampling was then guided by the
emerging findings.
UK community leaders. We purposefully recruited South
Asian ‘‘community leaders’’ ensuring that we had males and
females, those from key relevant ethnic (i.e., Indian, Pakistani, and
Bangladeshi) and faith (i.e., Hindu, Muslim, and Sikh)
backgrounds, and those occupying formal and informal national
and more local UK leadership roles. Ethnic and faith identity were
self-described by participants. Study information materials were
translated into the main relevant languages (i.e., Hindi, Urdu,
Gurmukhi, Gujarati, and Bengali).
Data Generation and Analysis
Interviews with researchers and community leaders were
conducted either face-to-face or by telephone by an experienced
qualitative researcher and social anthropologist who is of Indian
Muslim Gujarati origin (LH). Topic guides, which were developed
through our readings of the academic and policy literature and
previous experiences of undertaking research with minority ethnic
populations over a number of years, were used to help guide
discussions (see Texts S1 and S2); care was taken, however, to
ensure that these did not inappropriately constrain discussions.
Interviews lasted 15–60 min. Interviewees were given the option of
receiving a copy of the transcript. Because of a concern that the
researcher participants might be reluctant to disclose their true
feelings on a potentially sensitive subject, they were also given the
opportunity to complete a confidential questionnaire after the
interview, with the added option of posting anonymised comments
onto a closed Web site (see Text S3).
Face-to-face and telephone interviews were digitally recorded,
translated where necessary, and transcribed together with accom-
panying field notes. Data were analysed using the Framework
approach, a method developed for social policy research and
particularly suited to handling large datasets [16]. The following key
stages to analysis were included: familiarisation; identifying a
thematic framework; indexing; charting; mapping; and interpreta-
tion. Several techniques were used to ensure procedural clarity and
systematic, verifiable, approaches to analysis; these included
consistent availability of topic guides, digital audio-recording,
independent preparation of the verbatim transcripts, checking of
the translations against the original audio-file, standardised coding
and analysis of the data, and the creation of an analysis audit trail to
document analytic decisions. The process of data analysis was
iterative, in which issues raised by participants (e.g., ‘‘critical
incidents’’) were fed into subsequent interviews; further assisted
through weekly discussions between the researcher (LH) and
principal investigator (AS), and additional regular discussions of
findings with the broader multidisciplinary, multi-ethnic, and
multifaith research team with relevant expertise in respiratory
medicine, primary care, ethnicity, anthropology, public health, and
epidemiology/statistics. Interpretation of findings was enhanced by
regular reference to the relevant theoretical and empirical literature
on ethnicity and healthcare [4,5,8,17–20]. In order to assess the
robustness of our findings we actively sought out data offering
alternative possible interpretations. Data collection continued to
saturation, i.e., the point at which no major new ideas/perspectives
were emerging. We anticipated that this would occur after
interviews with approximately 30 to 40 researchers and ten to 15
community representatives on the basis of their anticipated more
limited experiences of participating in research.
Reflexivity
Care was taken throughout the process of designing the study,
identifying co-investigators, developing data collection techniques,
sampling, data generation and analysis to ensure that we
considered our own potential biases and that we did not force
our own preconceived notions on participants or allow our views
unduly to colour our interpretation of these data [21,22].
Results
A total of 43 (21 UK and 22 US) invitations were sent out to
asthma researchers. Four (two US and two UK) invitees did not
respond. Of the 39 that responded, three (US) declined. Given that
relatively few UK researchers had any research experience of
working with minority ethnic people, we additionally sampled
three UK social science researchers with substantive experience of
working with minority ethnic people. Thirty-three asthma
researchers (16 UK and 17 US) and a further three UK social
scientists participated in the study, and of these 26 completed the
supplementary questionnaire. Researchers were recruited from a
wide range of disciplinary backgrounds (see Table 2). A total of 11
invitations were sent out to community leaders, of whom one
declined. Ten interviews were conducted with community leaders;
our sample included males and females from diverse ethnic and
religious backgrounds (see Table 3).
We first discuss the data arising from the perspectives of asthma
researchers and then proceed to consider the findings from the
community leader interviews.
Asthma Researchers
Interview data. Key issues to emerge from these interviews
that can help to explain the differences in recruitment rates
between the UK and US include: the importance assigned by
researchers to the issue of recruiting minority ethnic people;
stereotypes and prejudices; different political contexts; and, above
all, the impact of the NIH’s policy in the US [11]. We consider
each of these subject areas in turn.
Attitudes of UK and US researchers towards inclusion and
policy considerations. The interviews with UK researchers
revealed a wide range of opinions on the subject of minority ethnic
Table 1. Participants and methods for data generation.
Participants
Data Generation
Technique
Numbers
Approached
Numbers in Final
Dataset
Asthma
researchers
Interview 43 36 interviews
Supplementary
questionnaire
26 supplementary
questionnaires
Community
leaders
Interview 11 10
doi:10.1371/journal.pmed.1000148.t001
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recruitment. The views can broadly be divided into three categories:
(i) a minority who did not see targeted inclusion of ethnic minorities
as having any scientific value except, possibly, in some very specific
contexts; (ii) those articulating views that were in general supportive
of broader inclusion for most studies (with several exceptions), but
with concerns about the practicality of recruiting subjects, viewing
the imposition of targets as impractical and even counter-
productive; and (iii) those who were committed to a policy of
inclusion similar to that introduced by the NIH. The majority of
UK researchers tended to fall into the second category, whereas the
majority of US researchers tended to fall into the third category.
Some UK researchers displayed a degree of antipathy towards
NIH-type targets for inclusion that were perceived to be
introduced for political rather than scientific reasons, describing
this as ‘‘politicians responding to the political correctness brigade’’ (AR05).
Another researcher also expressed concern about the NIH targets,
commenting ‘‘I think it is probably pandering to political correctness’’
(AR23); after a discussion on the pros and cons of mandatory
targets, the researcher concluded, ‘‘…so I think I would not be in
favour of …funder led guidelines.’’ The following parody, introduced in
a discussion on the relative merits of positive discrimination,
reflects some of the concerns that were expressed: ‘‘So I’ve got two to
go, I need one fat white bald smoker and I need one thin young Asian woman,
non-smoker … maybe we should be recruiting more people with multi-
pathologies. I bet we don’t have enough hypertensives in our asthma studies’’
(AR13). This researcher went on to emphasise that the issue was:
‘‘Not just about ethnic minorities!’’. Such views were barriers to more
inclusive recruitment practices and one researcher suggested that
‘‘it has to be a societal change and most of these changes cannot come by
enforcing it, it comes by people wanting to change it’’ (AR39). The practices
of a number of UK researchers pointed towards lack of
commitment, interest, or will. For most researchers, ‘‘the issue
hasn’t been given much thought’’ (AR24). As one researcher said, ‘‘not
recruiting minorities is sort of left over from having a very cohesive mono-
culture’’ (AR29).
In contrast, US researchers were, on the whole, more positive
about the importance of recruiting minority ethnic people on
scientific grounds than their UK counterparts as reflected, for
example, in the views of this researcher: ‘‘I think there is now a strong
likelihood that we will discover important differences and for that reason I think
it is important to try to push [for inclusion of minority ethnic people]’’ (AR41).
Stereotypes and prejudices. Our study also found evidence
that some UK researchers’ perceptions of, and attitudes towards,
ethnic minorities may have played a role in influencing
recruitment decisions, some of which are considered below.
Reflecting on some of the barriers to participation in studies or
engaging with research, one researcher drew on his own
experiences of caring for large numbers of South Asians in his
practice; ‘‘First generation migrants direct from the Indian sub-continent tend
not to have the skills …to deal with and process information in a digestible
form’’ (AR14). Earlier on in the interview, this researcher had
however pointed to the differences in trying to engage with more
established subgroupings within the South Asian population, this
in turn reflecting their integration within society as a whole: ‘‘Their
[Indian] children move fast, because when they came to England. Most of them
got jobs, they like the Bengalis they have a big sense of family, but unlike the
Bengalis they do their best to ensure that their children will have a good
education and go to university and get a good job. Whereas the Bengalis don’t
really give a s***!’’
One researcher, in the context of a discussion contrasting
Western European philosophies and society with Eastern self-
interested societies, presented ethnic minorities as lacking altruism
saying: ‘‘They are more orientated towards their family and less towards
society as a whole, or possibly, which is even worse, that they are only willing to
Table 2. Characteristics of asthma researchers.
Researcher
Number Location
Recruited/
Targeted Ethnic
Minorities Discipline
AR01 UK No Primary care
AR02 US Yes Respiratory consultant
AR03 UK Yes Social scientist
AR04 UK No Primary care
AR05 UK No Environmental and
occupational medicine
AR06 UK No Primary care
AR07 UK No Basic scientist/immunologist
AR08 UK Yes Respiratory consultant/
journal editor
AR09 US Yes Allergy and immunology
physician
AR11 UK Yes Primary care
AR12 US Yes Primary care
AR13 UK No Primary care
AR14 UK Yes Primary care
AR15 UK No Epidemiologist
AR16 US Yes Respiratory physician/
journal editor
AR17 UK Yes Health policy and health
education
AR18 UK Yes Social scientist
AR19 US Yes Epidemiologist
AR20 UK No Epidemiologist/basic
scientist/geneticist
AR21 UK Yes Social scientist
AR22 UK Yes Basic scientist
AR23 UK Yes Epidemiologist
AR24 UK No Geneticist
AR27 UK Yes Basic scientist/
epidemiologist
AR29 US Yes Statistician
AR30 US Yes Epidemiologist/geneticist
AR35 US Yes Epidemiologist/health
educationist
AR37 US Yes Sociologist/behavioural
scientist
AR38 US Yes Epidemiologist/statistician
AR39 US Yes Translational scientist
AR40 US Yes Clinical professor
AR41 US Yes Basic scientist
AR42 US Yes Pharmacist/health
economist/editor
AR43 US Yes Health educationist/
qualitative researcher
AR44 US Yes Basic scientist
AR45 US Yes Psychologist/educationalist
Apart from the three UK social scientists, all the interviewees have worked and
published on asthma. Most of them have interests in overlapping areas of
health research. The three social scientists were chosen because of their interest
and work on ethnicity and health research. Identifiers have been kept to a
minimum to avoid the risk of inadvertent disclosure of identity.
doi:10.1371/journal.pmed.1000148.t002
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contribute to the society where they come from…’’ (AR15). He went onto
describe South Asian people as ‘‘…a little bit selfish,’’ this reflecting,
more generally, their perceived relative lack of engagement in
society.
There was also a feeling among some researchers that ethnic
minorities may not comply with instructions and that they are
unreliable, which was raised in the context of a discussion on
illegal immigration and the use of pseudo-names: ‘‘When you have
people who are unreliable for whatever reason, they should be excluded and
that’s not a racial thing, it is just a judgement on reliability’’ (AR05).
In contrast, the attitude of most US researchers is reflected in
the views of these researchers:
‘‘We have to accept that these people [ethnic minorities] are part of the
population and that means respect and it means learning to live with
diversity and pluralism’’ (AR35).
‘‘And I think the other thing is, and again this sounds very simple, I
think it’s just, you know, as you would treat anybody, you treat them
with considerable dignity…And I think that becomes very, very
important and you recognise their special needs…Very, very important.
And you try to be obliging without being overbearing’’ (AR27).
The numerous challenges associated with recruiting ethnic
minorities led several UK and US researchers, irrespective of their
personal commitment to the idea, to view it as a major ‘‘hassle’’
with considerable implications in relation to ‘‘time, effort and resource’’
(AR05). There was, in general, also considerably more optimism
from US researchers when compared to UK researchers regarding
their ability to engage with minority communities, which seemed
to be a reflection of both greater commitment and the confidence
resulting from previous successful engagements. Several research-
ers thus noted that the logistical barriers were not insurmountable,
their experiences indicating that ethnic minorities do participate if
appropriately approached. As one US researcher noted:
‘‘We may, we’ll make up to 50, 60 telephone calls trying to get
somebody. I mean, this is extremely labor intensive. We will, if we get
set someone enrolled and we need to collect data and they can’t do it by
telephone, we send someone to their house. We take it very, very
seriously…it’s not just a matter of ringing someone up once or twice and
if it doesn’t work calling it a day. You know, you have to be ready, and
this costs money…’’ (AR02).
This view of increased costs associated with recruiting minority
ethnic people was, although widespread, not universally shared by
US researchers. One researcher, for example, who was committed
to the importance of inclusiveness in research, when asked about
increased costs associated with recruiting minority ethnic people,
retorted: ‘‘I don’t believe any of that!’’ (AR38).
Finally, US researchers frequently expressed concern at the
possibility of excluding minority ethnic people, as for example,
reflected by this researcher: ‘‘You know, most – I find it hard to… I find
it hard to accept there are researchers who will not work with an Asian
population or an ethnic diverse population or however you want to group them’’
(AR35).
Demographic, political, and socioeconomic contexts of
the two countries. Both US and UK researchers either pointed
out or accepted the fact that the demographic profile of ethnic
minorities, their histories, political engagement, influence, and the
way the health services are configured in the two countries also
contribute to differential recruitment rates in the two countries.
For example, one participant said: ‘‘the Tuskegee study is still a legacy
that sticks with our community in terms of research particularly when a lot of
our researchers are White’’ (AR37) [23,24].
The US population is largely served by the private health sector
through insurance. As minorities are less likely to be insured,
participating in an asthma study potentially has the added
advantage of receiving free medical attention making it more
attractive for minorities in the US to participate in research:
‘‘Most of our people living in the inner city have you know, government
supported insurance….So that helps that it means they’ll get their drugs
covered, you don’t charge for visits, you know, that’s [part of the study
and in some of the studies we actually provide them with medication so
they don’t actually have to go to the pharmacy and deal with the
hassle’’(AR27).
Such incentives in some instances do not motivate interest in
participating in studies: ‘‘…a lot of times we have difficulty getting White
patients because they don’t need the medication. Why would they take two hours
out of their day to drop downtown and do this research study?’’ (AR37).
NIH policy and its impact on attitudes and experiences in
the US contrasted with the UK. Our data suggest that the
introduction of the NIH policy had a major impact on the
attitudes and experiences of US researchers and probably explains
much of the differences in perspectives and experiences noted
above. Salient features of the NIH policy are summarised in Box 1
[11].
We found that most US asthma researchers currently accept the
stipulation of the NIH policy and had as a consequence devised
creative strategies to address the challenge of recruiting margin-
alised groups including, for example, community leaders being
‘‘hired as study personnel’’ so that they in effect became study
employees, thereby making it ‘‘legitimate to pay them’’ and
cooperating with other research teams ‘‘so, when a racial or ethnic
difference seems to be important, we co-operate with another area that has
subjects we can recruit’’ (AR29). There was an expressed greater
willingness to work with people ‘‘in their own territory,’’ including
going into ‘‘their own homes or in a community centre’’ or hosting free
‘‘community events’’ such as ‘‘barbecues’’ (AR35) or setting up study
clinics in accessible places such as ‘‘in a suburban shopping mall or some
place that’s right next to the bus stop or tube stop or…they can just walk right
in. Or they can just drive right up and walk right in to see you’’ (AR38).
Table 3. Characteristics of community leaders.
Community
Leader
Number
Ethnic/Religious
Background Leadership Role
CL02 Pakistani Muslim Local role; formal and informal positions
CL03 Indian Muslim National role; volunteer
CL04 Indian Muslim Local role; volunteer; no formal position
CL05 Bangladeshi Muslim National role; volunteer
CL06 Indian Hindu Local role; formal position
CL07 Indian Hindu Local role; no formal position
CL08 Indian Sikh National and local roles; volunteer
CL09 Indian Muslim Local role; volunteer
CL11 Indian Hindu National role; formal position
CL13 Indian Sikh Local role; formal position
Identifiers have been kept to a minimum to avoid the risk of inadvertent
disclosure of identity.
doi:10.1371/journal.pmed.1000148.t003
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There were also instances in which the NIH took a more
proactive role:
‘‘I’m thinking of our first study where we really were working in a
school and kind of recruiting what you would call difficult populations.
We were lucky because it was a contract from NIH where there were
several people that were contracted to do the same type of work and NIH
got us together on a regular basis and I think we were able to help each
other’’ (AR37).
The strategies adopted were typically resource and time
intensive as well as diverse as researchers tailored their approaches
to take into account both the nature of the study they were
conducting and the social context within which they were working.
Though only NIH funded studies are required to recruit and
report on ethnicity, the policy appears to have had a wider impact
beyond NIH funded studies. ‘‘It’s pretty much an expectation so I think it
really does filter down if you, … have a similar organization that’s well
respected I think people start to look at that [NIH policy] as really the gold
standard’’ (AR37). Thus although pharmaceutical companies are
not bound by quotas they are answerable to the Food and Drug
Administration (FDA), which requires ‘‘…evidence that the drug’s not
acting differently in one group than another’’ (AR29).
There was resentment in the US when NIH policy was first
introduced as it was seen as a political move. ‘‘I think it was entirely
political…’’ (AR41). ‘‘They [researchers] hated it … and they wrote every
excuse in the book of why they shouldn’t have to do it’’ (AR12). ‘‘It was
clearly difficult for us in the beginning’’ (AR41). However, with new
evidence emerging, there seems to be more conviction in the US.
‘‘It’s hard to argue that having a reasonable amount of demographic diversity
isn’t scientifically revealing. I think now there is a strong likelihood that we will
discover important differences and for that reason I think it’s important to try to
push even if it’s a political argument for pushing’’ (AR41).
A few researchers felt that it would be better if they did not have
to pursue targets for certain studies. Nevertheless, not a single US
researcher questioned the benefits of minority inclusion or called
for it to be eliminated. In spite of the apparent commitment, it was
felt by some that ‘‘they’d go right back’’ (AR12) if the NIH no longer
insisted on the need for recruitment of minority people.
The overall importance and impact of the NIH policy was well
summarised in the following words:
‘‘All of us who are working with NIH grants, we have to indicate the
percentage of minority people that will be involved in our grants and we
have to report on a quarterly basis how we are doing on recruitment.
And if we’re not doing well on recruitment we hear from our programme
officer and one can lose a grant if recruitment isn’t as it needs to be and
this is because NIH had a lot of difficulty in years past with giving
grants and at the end people would say, well you know what, we just
couldn’t recruit the people and so NIH said well we don’t think it’s a
good investment of our money…’’ (AR02).
Unlike the US, there is no comparable policy existing in the
UK. Most UK researchers did not believe that existing laws and
guidelines required them to include ethnic minorities in their study
though some did express the view that the Race Relations
Amendment Act [25] and the Human Rights Act [26] clearly puts
the onus on researchers to ensure that their study sample is
representative of the population under study and that no group is
excluded from the benefits of research.
UK researchers did not specifically target or monitor ethnic
minorities unless the study question specifically required them to
do so. Most researchers ‘‘just simply advertise’’ (AR20) and ‘‘recruit
people regardless of their ethnicity as they come through the clinics’’(AR24)
and have not ‘‘particularly monitored the ethnic minorities within the group
… [they] used’’ (AR07). ‘‘As long as you capture the data that’s fine, but to
deliberately go out and say, ‘I must recruit X number of Asian …’ just doesn’t
make sense’’ (AR05).
The standard response, even from those who whole-heartedly
supported the idea of inclusion, was that this consciousness was not
translated into action in terms of research strategies. ‘‘We never put
positive discrimination … you know we haven’t done historically … you get
people who come’’ (AR17).
Questionnaire data. Supplementary questionnaires (see
Text S3) were completed by 26 researchers (72% overall: 74%
UK and 71% US). The findings were in close agreement with
those elicited through interviews but did offer a few additional
insights into the barriers facing researchers in recruiting minority
populations and the observation that UK researchers perceived
that this subject was a relatively unimportant issue for funders and
journals. The majority of UK researchers in support of this
position and who thought this issue was important for journals and
funders were themselves from social science backgrounds and/or
from minority ethnic groups, whereas researchers in general in the
US considered this to be a particularly important issue for funding
bodies. None of the respondents expressed a wish to post
anonymised comments onto a Web site.
Perspectives of UK Community Leaders
The main themes to emerge from the interviews with community
leaders included a lack of awareness of and/or opportunities to
participate in research, a general expressed willingness to get
involved if invited to do so, particularly if cultural sensitivities and
logistical considerations were adequately attended to. There was,
however, some concern from those who had helped facilitate
research that involvement carried opportunity costs, which were not
always adequately recognised or reciprocated. These issues have
policy implications in relation to the skills and resources researchers
need to make such relationships mutually fulfilling.
Lack of awareness of research and opportunities to
participate. A number of the community leaders had little
experience of being asked to help recruit participants or, for that
matter, personally being invited to participate in research, whether
in the context of asthma or indeed any other research.
‘‘Well first of all I think the most important thing is the media. It
should be put through the media because people must know what is
asthma. The Asian community and where they can go and how they can
come forward if there’s any research going on. Nobody knows about it. I
don’t know anything about it. Personally I don’t know anything about it
unless somebody approached me and talked to me to tell me what it is,
then I would know it’’ (CL03).
This lack of engagement with research appeared to be
widespread, often resulting in the lack of any broader opportu-
nities to learn informally through friends and family members, for
example about research participation and what it might entail.
I: Have you ever been approached for any health research projects?
CL02: No.
I: Never?
CL02: No.
I: …Do you know of anyone who’s ever participated in health research?
CL02: No, not that I know of, no. (CL02)
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Those who had some connection with the medical profession,
either themselves being doctors or working with medical
colleagues or through their respective organisations, were in
contrast more likely to have been approached to help recruit
participants, although such approaches tended to be relatively
infrequent. Given the relatively high proportion of South Asian
doctors in the UK, drawing on the support of such individuals
could prove very useful, although there is the associated risk of
possible gatekeeper fatigue (discussed below).
Recognition of the importance of this field and a
willingness to engage if invited to do so. There was widely
held and strongly expressed support for the involvement of
minority ethnic communities in research, which was argued for on
the grounds of fairness and justice, the need to reduce the high and
disproportionate levels of morbidity, and, more generally, in order
to better understand the changing nature of minority ethnic
communities. Responding to a question on the appropriateness or
otherwise of this enquiry, one leader, for example, commented
that such studies were: ‘‘Oh absolutely essential. I think one of the
problems is that we don’t know enough formalised studies. We don’t know
enough about people generally, you know, what they think, how they’re perceived
and so forth…’’ (CL04).
There was amongst some leaders, although certainly not all, a
detailed appreciation of discrimination and equality legislation,
which they were able to draw on to inform their responses in the
context of discussions on research. Reference was in this respect
made to, amongst other considerations, ‘‘the Race Equality Scheme’’
and the ‘‘Commission for Equality and Human Rights’’ (CL11), which
were mentioned to underscore the importance of fairness for all
members of society [25,26].
A sense of responsibility towards community members also
served as an important motivating factor:
‘‘But there is a lot of ways we can help you. We will do our best to
assist you in whatever way we can. We are here to see our community
benefit. Doesn’t matter whether it’s Pakistani, Indian, Bengali. We
work with every one of them. So we will try and help as much as
possible from this office. So our doors are open to you at any time’’
(CL03).
Perhaps, ever more telling, was that a number of the community
leaders interviewed went out of their way to help recruit people
with asthma and carers for the focus group component of this
work.
Recognising the need to ensure cultural sensitivity and
opportunity costs. There were a number of suggestions made
on how recruitment might best be encouraged centring on the
need to ensure that the language needs of minority ethnic
communities were adequately met and that cultural and religious
and cultural values, such as the need for gender segregation, were
respected:
‘‘Particularly, if you’re handling the women, you have to be very careful.
You know that, in Islam, there are certain things that the women don’t
like. They’d rather they be handled by a female doctor, rather than
handled by a male doctor’’ (CL03).
The need to think about convenience, recognising that people
had busy lives, was also emphasised particularly as many are
disadvantaged and hence would find it difficult to meet
transportation costs, for example. Interviewees also reflected on
the lack of capacity that their respective organisations had to
facilitate such additional noncore work and that if they did engage
with such requests this would have opportunity costs.
‘‘Many mosques and centres don’t have that capacity because of the
constraint in financial sources…they don’t have enough people…we are
encouraging our mosques and centres to work with the local community,
local council, local service providers like hospitals and others and it’s
gradually getting through, but there has to be reciprocal attempt from the
service provider’’ (CL05).
Finding ‘‘a carrot’’ of some sort for the organisation was
suggested as potentially important in helping to address such
barriers; the community organisations’ needs in this respect tended
to be relatively modest such as ‘‘hall hire…for a Sunday afternoon’’ or
paying for ‘‘a dinner’’ (CL06). Although these suggestions were in
keeping with the types of activities already being undertaken by
many US researchers, such initiatives would require new ways of
working by UK academics and funding bodies, as such activities
have funding implications that are typically not budgeted for in
research applications.
One of the leaders who had the most experience of facilitating
research in the past was, while retaining appreciation of the
importance of the subject, very negative about many of her own
organisation’s experiences as the approaches were often seen as
‘‘tokenistic’’ or ‘‘last gasp’’ attempts when other approaches had
failed. This then led her to question her personal involvement:
‘‘You know after years and years of taking part and then thinking ‘Well you
know what does happen with all that stuff?’ Nobody ever gets back to us about
it…So since then I have been very cynical and very careful and I ask a lot of
questions and I would want to know what it is that we are going to get out of
this’’ (CL13).
Discussion
This study has revealed a wide gap between the US and UK in
terms of policy, attitudes, practices, and experiences in relation to
the inclusion of minority ethnic people in asthma research. These
differences should not, however, mask the broader convergence of
policy and scientific interest in relation to the question of
inclusiveness of diverse populations, which was evidenced in the
views expressed by a number of US and UK academics. There was
also a similarity in views on the logistical and resource implications
of broadening recruitment beyond the majority white population.
Whereas the NIH policy appears to be a major driving force for the
more inclusive ethos in the US, the absence of such a policy in the
UK coupled with antipathy, inexperience, and apprehension
contribute towards the marked relative under-representation of
ethnic minorities in UK asthma studies. Our findings suggest that a
US-style legislative-based approach could, if suitably adapted for a
UK context, bolster recruitment of minority ethnic people into UK
research, both in relation to asthma and possibly in other areas.
Focusing attention on this issue would also, it seems, eventually
promote engagement of researchers with minority ethnic commu-
nities in mutually respectful and fulfilling ways.
Strengths and Limitations of This Study
This is the first trans-Atlantic study of its kind, to our
knowledge, which builds on previous quantitative work and
consequently sheds light on a question that we believe is of
international importance. This study complements the previous
descriptive work and offers insights into why the now well-
described differences in recruitment rates between the US and UK
exist. Given the nature of the insights obtained and that these
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differences between the US and UK have also been noted in
research in conditions other than asthma, our findings are likely to
be transferable to other disease areas and contexts [6,27]. Our
previous work has shown that UK researchers are probably more
aware of this issue of ethnic representation than researchers in
many other parts of Europe; therefore we suspect these findings
will also be transferable to other parts of Western Europe [5,6,10].
There is a small, but nonetheless inevitable risk that, given the
sensitive nature of the question under study, participants may have
at times felt obliged to give ‘‘politically correct’’ answers. On a
related point, the views of the research team on the importance of
thinking about ethnicity considerations in the context of research
are well known and so these views could also have acted as a bar to
frank discussion. We anticipated the potential importance of these
issues and so took care to ensure that interviews were conducted in a
nonjudgmental manner thereby allowing free and frank conversa-
tion; we made clear to participants that members of the research
team other than the interviewer would only have access to
anonymised material, and offered interviewees the option of
completing an electronic questionnaire (together with the option
of posting completely anonymised comments onto a dedicated Web
site) after the interview. Of related importance, care needs to be
taken in interpreting the data from questionnaires as they were
obtained from nonrepresentative samples, which limits the ability to
generalise from these data. Bearing in mind the main aim of the
questionnaire, it was encouraging that there were no additional
major issues arising that had not previously been covered in the
interviews; the absence of researchers’ anonymised comments on an
offered Web site may suggest that a public forum was superfluous,
but it may alternatively reflect the fact that researchers were
unconvinced that comments could not be attributed or that they
were too busy to engage further with this study.
The difficulties of defining who is and who is not a ‘‘community
leader’’ are well recognised. Part of the problem in this respect is
the concern that there are sometimes self-defined leaders who have
relatively little direct influence on their communities. In order to
try and work around this issue we sought to recruit individuals
with both formal and informal positions at national and local
levels. We were also keen to recruit community leaders from across
the three main faith groups of interest—Muslims, Hindus and
Sikhs—and for this reason we, in particular, sampled those of
Indian background (as the overwhelming majority of Pakistani and
Bangladeshi community leaders are Muslims). The interviews with
the community leaders in which they expressed a willingness to
participate in research need also to be interpreted cautiously as it is
well recognised that there is often a gulf between intentions and
actual practice; nevertheless, the overwhelming majority of the
community leaders who were invited to participate in this study
agreed to do so, which bodes well for other similar approaches.
Furthermore, many of these individuals actively helped with
recruiting people with asthma for the focus groups.
More fundamentally, some may question the main premise
underpinning this research, namely that taking ethnicity into
consideration when recruiting into research is in itself of
importance. It has for example recently been argued by Epstein,
among others, that the scientific arguments underpinning this drive
to promoting inclusion are of questionable scientific value [28]. Our
view, formulated over the course of several years of work in this
area, is that contextual considerations are potentially of considerable
importance when reflecting on the scientific importance of ethnicity
as a variable; overall, however, there is as yet inadequate data to be
able to decide which contexts are of greatest importance, and so in
order to progress understanding in this field at this stage there is a
need to promote greater inclusiveness in research. We also believe
that there are important societal gains to be had from promoting
inclusion in research in multi-ethnic societies.
We may also be criticised for focusing on South Asians and
thereby excluding other minority ethnic populations. Our decision
to focus on this population was taken, as discussed in the
introduction, on the basis of demographic considerations and also
on the well-recognised and persistent asthma inequalities experi-
enced by South Asians. There were, however, also more pragmatic
considerations; in particular, the considerable difficulties in
obtaining support for research of this kind and in the face of
limited resources, the need to begin this research somewhere, while
also ensuring that it was undertaken in a way that was sensitive (e.g.,
in relation to meeting language needs) to the communities under
study. Our hope is that in due course we will be able to extend this
enquiry to other minority ethnic populations. The focus of this
work, which was in relation to bolstering recruitment of minority
ethnic people into UK research and the logistical constraints
discussed above, also guided our decision to only recruit UK
community leaders. Future research could usefully explore the
perspectives and experiences of US community leaders.
There is also the risk that through focusing attention on
ethnicity that we may inadvertently be exacerbating the problems
of marginalisation of these minority communities. Although we
acknowledge this as a potential risk, particularly in the short-term,
overall we believe that in the medium- to longer-term highlighting
exclusion issues will result in more benefit than harm.
Finally, there are, as with all qualitative work, questions about
how generalisable the findings are beyond the participants
included in this study. The underlying factors identified in
explaining these differences do suggest, however, that our findings
are potentially transferable to other minority ethnic populations
and other disease contexts.
How These Findings Relate to the Broader Literature
A key question that arose from the literature and our early
interviews was whether the NIH guidelines played a central role in
the US. It is important in this respect to note that the NIH is the
world’s biggest research funder with an annual budget of .US$28
billion. Our subsequent data showed that the policy not only played
an important role in the way NIH funded research is conducted, but
it also appears to have had a ripple effect in relation to non-NIH
funded research. This policy seems to have consequently increased
researchers’ experience, expertise, and confidence in approaching
and interacting with ‘‘hard to reach’’ (or alternatively ‘‘easy to
ignore’’) populations, and funders’ appreciation of the cost
implications of broadening participation. This work echoes the
findings of Wendler et al. [29], which demonstrated that the failure
to invite participants is an important barrier to participation.
Our data indicate that the possible benefits of participating in
research (such as free medical attention and routine use of
financial incentives) in the US may make participation attractive to
those who are uninsured (more commonly minorities). As there are
no such tangible benefits in the UK (the NHS is free and financial
incentives are seldom given), participants may not see the same
direct benefits. On a related note, there appears to be a general
unease about the offer of financial incentives or funding to
community groups to host events, which could facilitate recruit-
ment, because of concerns that this may result in coercion to
participate. Exclusion of ethnic minorities is, however, contrary to
the spirit and letter of the Race Relations (Amendment) Act and
Human Rights Acts [25,26], which highlight the importance of
equality of opportunity and respect for individual’s beliefs and
practices; the NHS Patient’s Charter more explicitly gives patients
‘‘…the right to choose whether or not you want to take part in medical
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research’’ [30], something which is currently being withheld from
many UK patients. This is also contrary to the UK Department of
Health’s Research Governance Framework, which also highlights
the importance of inclusivity in research [31].
Our findings also resonate with the findings reported by
Hussain-Gambles et al. [32,33], who demonstrated that research-
ers who do not see the benefits of an inclusive sample and who
operate from preconceived notions about a group are unlikely to
seek them out as study subjects. We were struck by the extent of
stereotyping expressed by some UK researchers, which suggests
that these views may not prove easy to challenge or modify in the
short-term. More generally, the lack of availability of appropriate
diversity training and the limitations of the training options that
are available does not help in this respect [34]. Engagement with
people from the communities in question—which our data suggest
can be achieved though not without incurring costs—will however
force the challenging of such stereotypes, and we hope this will
eventually result in more nuanced perspectives on these issues. We
also hope that over time the increasing move to working in larger
research teams will allow researchers to work with colleagues who
may have a different set of experiences in this respect. Although
some of these comments expressing stereotypical views may be the
result of specific experiences, they are most unlikely to be
generalisable across an entire ethnic or religious group. Moreover,
a community’s own experience of marginalisation, and disenfran-
chisement, even if imagined in some cases, cannot be ignored.
More encouragingly, we did uncover at least some examples in the
UK where substantial progress has been achieved in reaching out
to and engaging with minority ethnic communities and through so
doing facilitating their inclusion with research.
Conclusions and Recommendations
The crucial question from a policy perspective is whether the
UK needs or is indeed ready for an NIH-type policy on
recruitment of minority ethnic groups. This work demonstrates
that such a policy would be unpopular in the UK. However, the
US example suggests that if introduced appropriately, initial
resentment can give way to conviction and a change of attitudes.
The fact that many other US funding bodies and academic
institutions now implicitly require inclusion of minority ethnic
people—even though the law does not require them to do so—
suggests that there is a degree of commitment to the idea of
inclusion among the leaders and policy makers in the US scientific
community. An NIH-type policy, backed with legislation and
funding and other technical support [35] for researchers, instituted
by a UK funding body of national standing—such as the Medical
Research Council or the National Institute of Health Research—
would, we believe, probably have a major impact on the way
research is conducted in the UK. The Research Governance
Framework provides an important platform on which to build
such UK policy [31].
Given the considerable concerns expressed by UK researchers
about any move towards a mandatory NIH-type policy, it might be
argued that it is best initially to continue with the UK’s voluntary
codes of best practice exhorting researchers to recruit minority ethnic
people into their studies. However, given the degree of scepticism and
worries about logistics identified, and the US experiences, we believe
these voluntary codes are unlikely to translate into improved
outcomes unless there is considerable accompanying support for
researchers both in relation to ready access to expertise and also
financial and material support to develop long-term relationships
with the communities of interest. For inclusionary recruitment to
occur, funding bodies will need to both recognise its importance and
appreciate the use of funds being used to support the range of
community initiatives necessary to implement research.
If, however, such voluntary measures prove unsuccessful—
which is certainly possible—we hypothesise that an NIH-type
approach is a credible one that should be considered, as it will
most probably translate into substantial improvements in recruit-
ment rates. As with any hypothesis, however, it would need to be
tested to examine its credibility and also to ensure that such an
initiative does not inadvertently result in more harm than good.
Although the focus of this work was on comparing and
contrasting experiences between the UK and US, we suspect that
the implications of our findings will also apply to many other
multi-ethnic societies. Research funders, policy makers, research-
ers, and the minority ethnic communities themselves in other parts
of the world should therefore consider the implications of our work
and, if necessary, critically evaluate and reformulate the
recruitment procedures currently being supported and employed.
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Editors’ Summary
Background. In an ideal world, everyone would have the
same access to health care and the same health outcomes
(responses to health interventions). However, health
inequalities—gaps in health care and in health between
different parts of the population—exist in many countries. In
particular, people belonging to ethnic minorities in the UK, the
US, and elsewhere have poorer health outcomes for several
conditions than people belonging to the ethnic majority
(ethnicity is defined by social characteristics such as cultural
tradition or national origin). For example, in the UK, people
whose ancestors came from the Indian subcontinent (also
known as South Asians and comprising in themain of people of
Indian, Pakistani, and Bangladeshi origin) are three times as
likely to be admitted to hospital for asthma as white Europeans.
The reasons underpinning ethnic health inequalities are
complex. Some inequalities may reflect intrinsic differences
between groups of people—some ethnic minorities may
inherit genes that alter their susceptibility to a specific
disease. Other ethnic health inequalities may arise because of
differences in socioeconomic status or because different
cultural traditions affect the uptake of health care services.
Why Was This Study Done? Minority ethnic groups are
often under-represented in health research, which could
limit the generalizability of research findings. That is, an
asthma treatment that works well in a trial where all the
participants are white Europeans might not be suitable for
South Asians. Clinicians might nevertheless use the
treatment in all their patients irrespective of their ethnicity
and thus inadvertently increase ethnic health inequality. So,
how can ethnic minorities be encouraged to enroll into
research studies? In this qualitative study, the investigators
try to answer this question by talking to US and UK asthma
researchers and UK community leaders about how they feel
about enrolling ethnic minorities into research studies. The
investigators chose to compare the feelings of US and UK
asthma researchers because minority ethnic people are more
likely to enroll into US asthma studies than into UK studies,
possibly because the US National Institute of Health’s (NIH)
Revitalization Act 1993 mandates that all NIH-funded clinical
research must include people from ethnic minority groups;
there is no similar mandatory policy in the UK.
What Did the Researchers Do and Find? The
investigators interviewed 16 UK and 17 US asthma
researchers and three UK social researchers with experience
of working with ethnic minorities. They also interviewed ten
community leaders from diverse ethnic, religious and linguistic
backgrounds. They then analyzed the interviews using the
‘‘Framework’’ approach, an analytical method in which
qualitative data are classified and organized according to key
themes and then interpreted. By comparing the data from the
UK and US researchers, the investigators identified several
barriers to ethnic minority participation in health research
including: the attitudes of researchers towards the scientific
importance of recruiting ethnic minority people into health
research studies; prejudices about the difficulties of including
ethnic minorities in health research; and the logistical
challenges posed by language and cultural differences. In
general, the US researchers were more positive than their UK
counterparts about the importance and logistics of including
ethnic minorities in health research. Finally, the investigators
found that some community leaders had a poor
understanding of what research entails and about its aims.
What Do These Findings Mean? These findings reveal a
large gap between US and UK researchers in terms of policy,
attitudes, practices, and experiences in relation to including
ethnic minorities in asthma research. However, they also
suggest that most UK researchers and community leaders
believe that it is both important and feasible to increase the
participation of South Asians in asthma studies. Although
some of these findings may have been affected by the study
participants sometimes feeling obliged to give ‘‘politically
correct’’ answers, these findings are likely to be generalizable
to other diseases and to other parts of Europe. Given their
findings, the researchers warn that a voluntary code of
practice that encourages the recruitment of ethnic minority
people into health research studies is unlikely to be
successful. Instead, they suggest, the best way to increase
the representation of ethnic minority people in health
research in the UK might be to follow the US lead and
introduce a policy that requires their inclusion in such
research.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000148.
N Families USA, a US nonprofit organization that campaigns
for high-quality, affordable health care for all Americans,
has information about many aspects of minority health in
the US, including an interactive game about minority
health issues
N The US Agency for Healthcare Research and Quality has a
section on minority health
N The UK Department of Health provides information on
health inequalities and a recent report on the experiences
of patients in Black and minority ethnic groups
N The UK Parliamentary Office of Science and Technology
also has a short article on ethnicity and health
N Information on the NIH Revitalization Act 1993 is available
N NHS Evidence’s Ethnicity and Health has a variety of policy,
clinical, and research resources on ethnicity and health
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